Show simple item record

dc.contributor.authorJanssen, Kevin J H
dc.contributor.authorWolffs, Petra F G
dc.contributor.authorHoebe, Christian J P A
dc.contributor.authorHeijman, Titia
dc.contributor.authorGötz, Hannelore M
dc.contributor.authorBruisten, Sylvia M
dc.contributor.authorSchim van der Loeff, Maarten
dc.contributor.authorde Vries, Henry J
dc.contributor.authorDukers-Muijrers, Nicole H T M
dc.date.accessioned2021-01-25T10:21:55Z
dc.date.available2021-01-25T10:21:55Z
dc.date.issued2021-01-13
dc.identifier.pmid33441449
dc.identifier.doi10.1136/sextrans-2020-054533
dc.identifier.urihttp://hdl.handle.net/10029/624651
dc.description.abstractChlamydia trachomatis (CT) is routinely diagnosed by nucleic acid amplification tests (NAATs), which are unable to distinguish between nucleic acids from viable and non-viable CT organisms.en_US
dc.language.isoenen_US
dc.rights© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectChlamydia trachomatisen_US
dc.subjectanogenital conditionsen_US
dc.subjectbacterial infectionen_US
dc.subjectwomenen_US
dc.titleDeterminants associated with viable genital or rectal bacterial load (FemCure).en_US
dc.typeArticleen_US
dc.identifier.eissn1472-3263
dc.identifier.journalSex Transmit Infect 2021; advance online publication (ahead of print)en_US
dc.source.journaltitleSexually transmitted infections
dc.source.countryEngland


This item appears in the following Collection(s)

Show simple item record